ARTL · ARTELO BIOSCIENCES, INC.

💰 Cash Runway & Dilution Risk

ARTL holds $4.2M in cash and short-term investments (as of Jun 30, 2026) and burns about $3.1M/quarter from operations, an estimated runway of 4 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 100 · High

• Cash runway 4 months +40
• ATM program on file since May 2026 +15
• Shelf registration (S-3, May 2026) +10
• Going-concern doubt in the latest 10-Q +15These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. 10-Q, Aug 2026
• Share count +248% in a year +20

Recent financing filings on SEC EDGAR:

• May 26, 2026 · ATM program, up to $7M · 424B5
• May 18, 2026 · ATM program terminated · 424B5
• May 4, 2026 · Shelf registration, up to $69M · S-3
• Mar 30, 2026 · Private placement (8-K Item 3.02) · 8-K
• Mar 26, 2026 · Private placement (8-K Item 3.02) · 8-K
• Mar 20, 2026 · Registered direct / best-efforts offering · S-1

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when ARTL files for a raise →